MiR‐10a‐5p aggravates podocyte injury in diabetic nephropathy by inhibiting E2f7‐mediated autophagy

Documenti analoghi

• LncRNA VCAN‐AS1 serves as a diagnostic biomarker and drives pathogenesis in diabetic nephropathy via the miR‐205‐5p/VEGFA axis
  di: Jing Zhou, et al.
  Pubblicazione: (2026)
• The exosome‐ PI3K /Akt‐autophagy axis in diabetic vascular complications: Mechanisms and implications
  di: Wei Liu, et al.
  Pubblicazione: (2025)
• O‐linked β‐N‐acetylglucosamine (O‐GlcNAc) modification: Emerging pathogenesis and a therapeutic target of diabetic nephropathy
  di: Bingxue Qi, et al.
  Pubblicazione: (2024)
• A multifactorial intervention to improve cardiovascular outcomes in adults with type 2 diabetes and current or previous diabetic foot ulcer disease: Protocol for a multi‐centre randomised control trial ( MiFoot study)
  di: Tolu Onuwe, et al.
  Pubblicazione: (2025)
• Weight‐related discrimination, perceived stress and psychological and physical well‐being of persons with type 2 diabetes: A mediation analysis
  di: Samuel Akyirem, et al.
  Pubblicazione: (2024)